[Clinical experiences with the trimethoprim and sulfamethoxazole association in the treatment of chronic urinary tract infections].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014581:Urticaria / Q000139:chemically induced
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Klinische Erfahrungen mit der Kombination Trimethoprim und Sulfamethoxazol in der Therapie chronischer Harnwegsinfekte.